Pro-Dex Inc PDEX.OQ reported quarterly adjusted earnings of 36 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 46 cents. The lone analyst forecast for the quarter was for earnings of 47 cents per share.
Revenue rose 16.4% to $17.49 million from a year ago; analysts expected $17.90 million.
Pro-Dex Inc's reported EPS for the quarter was 36 cents.
The company reported quarterly net income of $1.2 million.
Pro-Dex Inc shares had risen by 6.5% this quarter and lost 0.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Pro-Dex Inc is $56.00, about 18.3% above its last closing price of $45.74
This summary was machine generated from LSEG data September 4 at 10:21 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.47 | 0.36 | Missed |
Mar. 31 2025 | 0.47 | 0.82 | Beat |
Dec. 31 2024 | 0.38 | 0.61 | Beat |
Sep. 30 2024 | 0.29 | 0.75 | Beat |